ليست عنوان مقالات لاتين Cardiac Procedures in Patients With a Body Mass Index Exceeding 45: Outcomes and Long-Term Results Cardiovascular Disease in Chronic Renal Failure Patients

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Cardiac Procedures in Patients With a Body Mass Index Exceeding 45: Outcomes and Long-Term Results

2

Cardiac progenitor cells application in cardiovascular disease

3

Cardiac protection during acute myocardial infarction: Where do we stand in 2004? Review Article

4

Cardiac protection: Evolving role of angiotensin receptor blockers

5

Cardiac Pseudopyogenic Granuloma: A Type of Vascular Hyperplasia in the Transplanted Heart Mimicking Pyogenic Granuloma

6

Cardiac pulsations in patients with isolated right ventricular infarction

7

Cardiac Regeneration Review Article

8

Cardiac Rehab: Bridging the Transition from Hospital to Home

9

Cardiac rehabilitation

10

Cardiac rehabilitation after myocardial infarction in the community Original Research Article

11

Cardiac rehabilitation and depression

12

Cardiac Rehabilitation and Prevention of Cardiovascular Disease: A Role for Autonomic Cardiovascular Regulation

13

Cardiac rehabilitation and secondary prevention in Australia and New Zealand

14

Cardiac Rehabilitation and Secondary Prevention Program effect in Chronic Total Occlusion Percutaneous Coronary Intervention patients

15

Cardiac Rehabilitation and Survival in Older Coronary Patients

16

Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction

17

Cardiac Rehabilitation Following Myocardial Infarction

18

Cardiac Rehabilitation for Patients With Ventricular Assist Devices: An Offer to Improve Strong Collaborative Relationships

19

Cardiac rehabilitation I: review of psychosocial factors

20

Cardiac rehabilitation II: referral and participation

21

Cardiac Rehabilitation Improves the QRS Fragmentation in Patients With ST Elevatıon Myocardial Infarction

22

CARDIAC REHABILITATION IN PATIENTS WITH DIABETES MELLITUS

23

CARDIAC REHABILITATION IN PATIENTS WITH DIABETES MELLITUS

24

Cardiac rehabilitation in skilled nursing facilities: A missed opportunity

25

Cardiac rehabilitation in the elderly

26

Cardiac Rehabilitation Program with High Intensity Aerobic Exercise Can Reverse Diastolic Impairment in Patients Undergoing Coronary Artery Bypass Surgery

27

Cardiac rehabilitation services in England and Wales: a national survey

28

Cardiac rehabilitation using simultaneous voice and electrocardiographic transtelephonic monitoring

29

Cardiac Rehabilitation, Exercise Training, and Anxiety

30

Cardiac Rehabilitation, Exercise Training, and Psychosocial Risk Factors

31

Cardiac Rehabilitation, Exercise Training, and Psychosocial Risk Factors: Reply

32

Cardiac rehabilitation: A review of current developments

33

Cardiac rehabilitation: How can it be improved?

34

Cardiac Relapse of Acute Myeloid Leukemia afterAllogeneic Hematopoietic Stem Cell Transplantation

35

Cardiac Release and Kinetics of Endothelin After Severe Short-Lasting Myocardial Ischemi

36

Cardiac Release and Kinetics of Endothelin After Uncomplicated Percutaneous Transluminal Coronary Angioplasty

37

Cardiac remodeling after long term norepinephrine treatment in rats

38

Cardiac remodeling after long-term stimulation by antibodies against the α1-adrenergic receptor in rats

39

Cardiac remodeling and failure: From molecules to man (Part I)

40

Cardiac remodeling and failure: From molecules to man (Part II)

41

Cardiac remodeling and failure: From molecules to man (Part III)

42

Cardiac remodeling and the role of matrix metalloproteinases in chronic anthracycline cardiotoxicity

43

Cardiac remodeling in coronary artery disease

44

Cardiac remodeling precedes clinical hypertension in offspring of hypertensive parents. The Bergen Blood Pressure Study

45

Cardiac remodeling rather than disturbed myocardial energy metabolism is associated with cardiac dysfunction in diabetic rats

46

Cardiac remodeling: is 8 the heart’s lucky number?

47

Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling

48

Cardiac remodelling in the era of aggressive medical therapy: does it still exist?

49

Cardiac reoperation by Carpentier bicaval femoral venous cannula: GATA experience

50

Cardiac reoperation in the intensive care unit

51

Cardiac reoperations in octogenarians: analysis of outcomes

52

Cardiac Repair in Patients with Trisomy 18: Total or Palliative?

53

Cardiac repair using chitosan-hyaluronan/silk fibroin patches in a rat heart model with myocardial infarction

54

Cardiac repolarisation can be detected as an ordered spatial process on the body surface

55

Cardiac Repolarization Changes in the Children with Breath-Holding Spells

56

Cardiac repolarization is prolonged in CD4C/HIV transgenic mice

57

Cardiac repolarization: Current knowledge, critical gaps, and new approaches to drug development and patient management

58

Cardiac rescue with intra-aortic balloon counterpulsation in refractory shock due to acute meningococcemia

59

Cardiac response to prolonged strenuous exercise: A physiologic model for stunning myocardium

60

Cardiac responses of vagus nerve stimulation: Intraoperative bradycardia and subsequent chronic stimulation

61

Cardiac responses to long duration and high magnitude +Gz exposure in pilots: An observational study

62

Cardiac Rest and Reserve Function in Patients With Fontan Circulation Original Research Article

63

Cardiac Restriction Secondary to Massive Calcific Deposits in the Left Ventricular Cavity

64

Cardiac Resurrection After Bone-Marrow-Derived Mononuclear Cell Transplantation During Left Ventricular Assist Device Support

65

Cardiac resynchronisation – a new standard in heart failure therapy

66

Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC

67

Cardiac Resynchronisation Therapy in Heart Failure

68

Cardiac Resynchronization and Quality of Life in Patients With Minimally Symptomatic Heart Failure

69

Cardiac resynchronization by pacing: an electrical treatment of heart failure

70

Cardiac Resynchronization Devices: The Food and Drug Administration’s Regulatory Considerations Review Article

71

Cardiac Resynchronization for Asymptomatic or Mildly Symptomatic Heart Failure: A Bridge Too Far?

72

Cardiac Resynchronization in Mildly Symptomatic Heart Failure and Asymptomatic Patients

73

Cardiac Resynchronization in Patients With Atrial Fibrillation: A Meta-Analysis of Prospective Cohort Studies Original Research Article

74

Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to biventricular pacing after chronic right ventricular pacing

75

Cardiac Resynchronization Therapy

76

Cardiac resynchronization therapy 101: If itʹs not late, pacing it early wonʹt help

77

Cardiac Resynchronization Therapy and Atrial Tachyarrhythmias: A Question Still Searching for an Answer

78

Cardiac resynchronization therapy can reverse abnormal myocardial strain distribution in patients with heart failure and left bundle branch block

79

Cardiac resynchronization therapy for an unusual cause of cardiomyopathy

80

Cardiac Resynchronization Therapy for Mitral Systolic Anterior Motion in a Child

81

Cardiac Resynchronization Therapy for the Failing Fontan Patient

82

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias

83

Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure Original Research Article

84

Cardiac Resynchronization Therapy Improves Heart Rate Profile and Heart Rate Variability of Patients With Moderate to Severe Heart Failure Original Research Article

85

Cardiac Resynchronization Therapy in Asymptomatic or Mildly Symptomatic Heart Failure Patients in Relation to Etiology: Results From the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) Study

86

Cardiac resynchronization therapy in chronic heart failure: How to select the patient that will benefit?

87

Cardiac resynchronization therapy in congenital heart disease

88

Cardiac Resynchronization Therapy in Patients With a Narrow QRS Complex Original Research Article

89

Cardiac Resynchronization Therapy in Patients With End-Stage Inotrope-Dependent Class IV Heart Failure

90

Cardiac Resynchronization Therapy in Patients With Left Bundle Branch Block Versus Right Ventricular Pacing

91

Cardiac Resynchronization Therapy in Patients With Minimal Heart Failure: A Systematic Review and Meta-Analysis

92

Cardiac resynchronization therapy in patients with narrow QRS

93

Cardiac Resynchronization Therapy in Patients With Systolic Left Ventricular Dysfunction and Symptoms of Mild Heart Failure Secondary to Ischemic or Nonischemic Cardiomyopathy

94

Cardiac Resynchronization Therapy Is More Effective in Women Than in Men: The MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) Trial

95

Cardiac Resynchronization Therapy May Avoid Dilated Rather Than Ischemic Cardiomyopathy Patients the Need for Primary Prevention Defibrillator Implantation

96

Cardiac Resynchronization Therapy Modifies the Neurohormonal Profile, Hemodynamic and Functional Capacity in Heart Failure Patients

97

Cardiac Resynchronization Therapy Optimization Using Trans Esophageal Doppler in Patients with Dilated Cardiomyopathy

98

Cardiac Resynchronization Therapy Reduces Left Atrial Volume and the Risk of Atrial Tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

99

Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay

100

Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony

101

Cardiac resynchronization therapy upregulates cardiac autonomic control

102

Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients

103

Cardiac resynchronization therapy, central sleep apnea, and Cheyne-Stokes respiration in chronic heart failure patients: Reply

104

Cardiac resynchronization therapy: A novel adjunct to the treatment and prevention of systemic right ventricular failure Original Research Article

105

Cardiac resynchronization therapy: A regulatory perspective

106

Cardiac Resynchronization Therapy: Antiarrhythmic or Proarrhythmic?

107

Cardiac Resynchronization Therapy: Are Modern Myths Preventing Appropriate Use?

108

Cardiac resynchronization therapy: caveat medicus! Review Article

109

Cardiac Resynchronization Therapy: Location Matters

110

Cardiac Resynchronization Therapy: Part 1—Issues Before Device Implantation Review Article

111

Cardiac Resynchronization Therapy: Part 2—Issues During and After Device Implantation and Unresolved Questions Review Article

112

Cardiac Resynchronization Therapy: The More Pacing Sites, the Better the Outcome?

113

Cardiac resynchronization therapyhomogenizes myocardial glucosemetabolism and perfusion in dilatedcardiomyopathy and left bundle branch block

114

Cardiac Resynchronization With Sequential Biventricular Pacing for the Treatment of Moderate-to-Severe Heart Failure Original Research Article

115

Cardiac resynchronization: a cornerstone in the foundation of device therapy for heart failure

116

Cardiac retransplantation in children

117

Cardiac rhabdomyoma

118

Cardiac rhabdomyoma in an adult patient presenting with right ventricular outflow tract obstruction

119

Cardiac Rhabdomyoma In Familial Tuberous Sclerosis

120

Cardiac Rhabdomyomas and Congenital Hypothyroidism: A Coincidence or Hamartia

121

Cardiac Rhabdomyomas and Obstructive Left Heart Disease: Histologically but Not Functionally Benign

122

Cardiac rhythm and symptomatic arrhythmia in right atrial isomerism

123

Cardiac rhythm disturbances in a bactrian camel (Camelus bactrianus) during anaesthesia for oral surgery: a case report

124

Cardiac Rhythm Management Devices: When Regulatory Agencies “Over-Regulate”

125

Cardiac risk factors

126

Cardiac risk factors

127

Cardiac risk for vascular surgery

128

Cardiac Risk in Patients Aged >75 Years With Asymptomatic, Severe Aortic Stenosis Undergoing Noncardiac Surgery

129

Cardiac risk in pregnant women with rheumatic mitral stenosis

130

Cardiac risk management in severe mental illness

131

Cardiac risk of noncardiac surgery in patients with hypertrophic cardiomyopathy

132

Cardiac risk stratification

133

Cardiac Risk Stratification in Renal Transplantation Using a Form of Artificial Intelligence

134

Cardiac risk: Theme con variations

135

Cardiac rupture – experience-based cardiology

136

Cardiac Rupture After Catheter Ablation Procedure

137

Cardiac rupture and tamponade during ventriculography

138

Cardiac rupture associated with thrombolytic therapy: Impact of time to treatment in the late assessment of thrombolytic efficacy (LATE) study

139

Cardiac rupture complicating myocardial infarction

140

Cardiac rupture during contrast-enhanced dobutamine stress echocardiography

141

Cardiac rupture during exercise test in post-myocardial infarction patients: a case report and brief review of the literature

142

Cardiac Rupture During Vacuum-Assisted Closure Therapy

143

Cardiac rupture or pericardial effusion?

144

Cardiac Sarcoidosis

145

Cardiac Sarcoidosis

146

Cardiac Sarcoidosis Detected by Late Gadolinium Enhancement and Prevalence of Atrial Arrhythmias

147

Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography

148

Cardiac sarcoidosis presenting as Heerfordt’s syndrome

149

Cardiac Sarcoidosis: A Contemporary Concept of Forgotten Granulomatosis

150

Cardiac Sarcoplasmic Reticular Function in Rats with Chronic Heart Failure Following Myocardial Infarction

151

Cardiac Sca-1+ and side population cells in cardiac regeneration

152

Cardiac screening proposed for HIV-1-infected children

153

Cardiac sensitization: methodology and interpretation in risk assessment

154

Cardiac signal extraction in patients with Implantable Cardioverter Defibrillators

155

Cardiac Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging: Finally Up to Speed?

156

Cardiac sources of embolic cerebral infarction in transesophageal echocardiography

157

CARDIAC SOURCES OF EMBOLISM IN IRANIAN STROKE PATIENTS

158

Cardiac specific haploinsufficiency of β-catenin attenuates cardiac hypertrophy from aortic constriction

159

Cardiac specific two-year mortality related to initial post-thrombolytic flow grade

160

Cardiac stabilizer for minimally invasive direct coronary artery bypass

161

Cardiac state diagnosis using adaptive neuro-fuzzy technique

162

Cardiac Steatosis and Left Ventricular Hypertrophy in Patients With Generalized Lipodystrophy as Determined by Magnetic Resonance Spectroscopy and Imaging

163

Cardiac Steatosis and Myocardial Dysfunction

164

Cardiac Stem Cell Transplantation

165

Cardiac stem cells and myocardial disease

166

Cardiac stem cells: paradigm shift or broken promise? A view from developmental biology Original Research Article

167

Cardiac stents: the next generation

168

Cardiac storage with University of Wisconsin solution and a nucleoside-transport blocker

169

Cardiac Strain between Normal Weight and Overweight Workers in Hot/Humid Weather in the Persian Gulf

170

Cardiac stress adaptation and hyperlipidemia: Role of matrix metalloproteinase-2

171

Cardiac Structural and Electrical Adaptation in Male Active Athletes. QT Interval Could it be the Clue to Sudden Cardiac Death?

172

Cardiac Structure and Exercise Blood Pressure in Urban and Rural Canadian Men of Icelandic Descent

173

Cardiac structure and function Review Article

174

Cardiac structure and function after short-term ethanol consumption in rats

175

Cardiac Structure and Function as Predictors of Mortality in Persons 85 Years of Age

176

Cardiac structure and function in fetuses of mothers infected with HIV: The prospective P2C2HIV multicenter study

177

Cardiac Structure and Function in Persons 85 Years of Age

178

Cardiac Structure and Function in Young and Senescent Mice Heterozygous for a Connexin43 Null Mutation

179

Cardiac sulfonylurea receptor short form-based channels confer a glibenclamide-insensitive KATP activity

180

Cardiac Surgeon Report Cards, Referral for Cardiac Surgery, and the Ethical Responsibilities of Cardiologists

181

Cardiac surgeons in England face publication of outcomes data

182

Cardiac surgery

183

Cardiac surgery and cold-reactive proteins

184

Cardiac surgery and the acute care nurse practitioner—“the perfect link”

185

Cardiac Surgery for Grown-Up Congenital Heart Patients: Survey of 307 Consecutive Operations from 1991 to 1994

186

Cardiac surgery for octogenarians: is it an informed decision?

187

Cardiac surgery in a fixed-reimbursement environment

188

Cardiac surgery in African Americans

189

Cardiac Surgery in Children With End-Stage Liver Disease Awaiting Liver Transplantation

190

Cardiac surgery in moderate to end-stage renal failure: analysis of risk factors

191

Cardiac surgery in nonagenarians: Pushing the boundary one further decade

192

Cardiac surgery in octogenarians with poor lung function

193

Cardiac surgery in octogenarians: can elderly patients benefit? quality of life after cardiac surgery

194

Cardiac surgery in octogenarians: have we gone too far or not far enough?

195

Cardiac surgery in octogenarians: The informed decision is not whether to have it, but rather when and where to have it

196

Cardiac surgery in patients infected with the human immunodeficiency virus

197

Cardiac Surgery in Patients on Dialysis: Decreased 30-Day Mortality, Unchanged Overall Survival

198

Cardiac Surgery in Patients With Body Mass Index of 50 or Greater

199

Cardiac surgery in patients with end-stage renal disease: 10-year experience

200

Cardiac Surgery in Patients With Liver Cirrhosis

201

Cardiac Surgery in Renal Transplant Recipients: Experience from Washington Hospital Center

202

Cardiac Surgery in Select Nonagenarians: Should We or Shouldn’t We?

203

Cardiac Surgery in the Adult, second edition: Edited by Lawrence H. Cohn, MD, and L. Henry Edmunds, MD, New York, McGraw-Hill Professional, 2003, 1573 pp, illustrated, $250.00, ISBN: 0-07139-1290

204

Cardiac surgery in the octogenarian: evaluation of risk, cost, and outcome

205

Cardiac surgery report cards: comprehensive review and statistical critique

206

Cardiac surgery report cards: making the grade

207

Cardiac surgery risk modeling for mortality: a review of current practice and suggestions for improvement

208

Cardiac Surgery Risk Models: A Position Article

209

Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia

210

Cardiac Surgery with Crystalloid Cardioplegia: Improved Functional Recovery Due to Molecular Adaptations in Adult Rat Hearts

211

Cardiac surgery: myocardial energy balance, antioxidant status and endothelial function after ischemia–reperfusion

212

Cardiac surgical conditions induced by β-blockade: Effect on myocardial fluid balance

213

Cardiac surgical implications of calcium dyshomeostasis in the heart

214

Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy

215

Cardiac Sympathetic Denervation Assessed With 123-Iodine Metaiodobenzylguanidine Imaging Predicts Ventricular Arrhythmias in Implantable Cardioverter-Defibrillator Patients

216

Cardiac sympathetic denervation detected with dobutamine infusion in patients with Parkinsonʹs disease: Correlation with cardiac 123I-metaiodobenzylguanidine (MIBG) uptake – A follow-up report

217

Cardiac Sympathetic Denervation in Patients With Coronary Artery Disease Without Previous Myocardial Infarction

218

Cardiac sympathetic denervationmodulates the sympathoexcitatoryresponse to acute myocardial ischemia

219

Cardiac Sympathetic Dysfunction Correlates With Abnormal Myocardial Contractile Reserve in Dilated Cardiomyopathy Patients Original Research Article

220

Cardiac sympathetic innervation and control of potassium channel function

221

Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardi

222

Cardiac Syndrome X and Endothelial Dysfunction: New Concepts in Prognosis and Treatment

223

Cardiac syndrome X versus metabolic syndrome X

224

Cardiac syndrome X: Clinical characteristics and left ventricular function: Long-term follow-up study

225

Cardiac T2* measurements in patients with iron overload: a comparison of imaging parameters and analysis techniques

226

Cardiac Tamponade After a Systemic–Pulmonary Shunt Complicated by Serous Leakage

227

Cardiac tamponade after removal of atrial intracardiac monitoring catheters in a pediatric patient: Case report

228

Cardiac tamponade as a complication of catheterization of the subclavian vein—prevention and principles of management

229

Cardiac tamponade as a life-threatening complication in antireflux surgery

230

Cardiac Tamponade as an Initial Manifestation of Cervical Cancer

231

Cardiac tamponade as initial presentation of Sheehanʹs Syndrome

232

Cardiac tamponade as manifestation of advanced thymic carcinoma

233

Cardiac Tamponade as the Initial Presentation of Acute MyeloidLeukemia: A Case Report with Review of the Literature

234

Cardiac tamponade as unusual presentation of underlying unrecognized cancer

235

Cardiac Tamponade by Hydatid Pericardial Cyst: A Rare Case Report

236

Cardiac tamponade caused by a leaking coronary saphenous vein graft aneurysm

237

Cardiac Tamponade Caused by Cutibacterium acnes: An Updated and Comprehensive Review of the Literature

238

Cardiac tamponade complicating trimodal therapy for malignant mesothelioma

239

Cardiac tamponade due to pneumopericardium

240

Cardiac tamponade due to spontaneous rupture of right coronary artery aneurysm

241

Cardiac tamponade during thoracic endovascular aortic repair

242

Cardiac tamponade following pacemaker implantation

243

Cardiac tamponade from central venous catheters

244

Cardiac Tamponade from Purulent Pericarditis due to Cutibacterium acnes

245

Cardiac tamponade in a neglected case of thyroid agenesis

246

Cardiac tamponade in a patient treated by sunitinib for metastatic renal cell carcinoma

247

Cardiac tamponade in acquired immunodeficiency syndrome

248

Cardiac tamponade in acute rheumatic fever

249

Cardiac tamponade in Hashimotoʹs disease

250

Cardiac tamponade in hereditary hemorrhagic telangiectasia

251

Cardiac Tamponade in Patients with COVID-19 Infection; A Case Report

252

Cardiac tamponade in the “new device” era: Evaluation of 6999 consecutive percutaneous coronary interventions

253

Cardiac tamponade in the fibrinolytic era: Analysis of >100 000 patients with ST-segment elevation myocardial infarction

254

CARDIAC TAMPONADE SECONDARY TO CARDIOPULMONARY RESUSCITATION IN APATIENT RECEIVING ANTIPLATELET THERAPY

255

Cardiac tamponade without pericardial effusion after blunt chest trauma

256

Cardiac Tamponade: A Rare Presentation of Childhood Hypothyroidism

257

Cardiac Tamponade; A rare Presentation of Childhood Hypothyroidism

258

Cardiac teratogenicity of trichloroethylene metabolites

259

Cardiac thromboemboli complicating a stab wound to the heart

260

Cardiac tissue engineering: characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures

261

Cardiac toxicity in breast cancer patients: From a fractional point of view to a global assessment

262

Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer

263

Cardiac toxicity of sunitinib

264

Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma: Schmidinger M, Zielinski CC, Vogl UM, Bojic A, Bojic M, Schukro C, Ruhsam M, Hejna M, Schmidinger H, Clinical Division of Oncology, Department of Medicine I and

265

Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease

266

Cardiac Transplant Following Failed Fontan or Glenn Procedures

267

Cardiac transplant rejection is associated with a decrease in the high-frequency components of the high-resolution, signal-averaged electrocardiogram

268

Cardiac transplantation after mechanical circulatory support: A Canadian perspective

269

Cardiac transplantation after the Fontan or Glenn procedure Original Research Article

270

Cardiac transplantation and simultaneous surgical repair of an aortic aneurysm

271

Cardiac Transplantation for Cardiac Sarcoidosis With Initial Diagnosis by Examination of the Left Ventricular Apical “Core” Excised for Insertion of a Left Ventricular Assist Device for Severe Chronic Heart Failure

272

Cardiac transplantation for hypertrophic cardiomyopathy associated with sengersʹ syndrome

273

Cardiac transplantation for the cardiologist not trained in transplantation

274

Cardiac Transplantation for The Iranian Journal of Cardiac Surgery Doxorubicin-induced Heart Failure after Chemotherapy of Ewing’s Sarcoma

275

Cardiac transplantation in a patient with protein S deficiency

276

Cardiac Transplantation in Adults With Aortic Valve Disease With Focus on the Bicuspid Aortic Valve

277

Cardiac Transplantation in Adults With Small Hearts

278

Cardiac Transplantation in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

279

Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy

280

Cardiac Transplantation in Pediatric Patients: Fifteen-Year Experience of a Single Center

281

Cardiac Transplantation: The Columbia University Medical Center/New York—Presbyterian Hospital Manual

282

Cardiac Troponin After Major Vascular Surgery: The Role of Perioperative Ischemia, Preoperative Thallium Scanning, and Coronary Revascularization Original Research Article

283

Cardiac Troponin After Percutaneous Coronary Intervention and 1-Year Mortality in Non–ST-Segment Elevation Acute Coronary Syndrome Using Systematic Evaluation of Biomarker Trends

284

Cardiac Troponin and Brain Natriuretic Peptide: Prediction of Mortality Among Septic Pts

285

Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan

286

Cardiac Troponin Elevation After Long-Distance Cycling is Associated with Oxidative Stress and Exercise Intensity: An Observational Study

287

Cardiac Troponin Elevations in Chronic Renal Failure: Prevalence and Clinical Significance

288

Cardiac troponin I

289

Cardiac troponin I and cardiac enzymes after electrophysiologic studies, ablations, and defibrillator implantations

290

Cardiac troponin I and creatine kinase-MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency

291

Cardiac Troponin I and Tension Generation of Skinned Fibres in the Developing Rat Heart

292

Cardiac troponin I and the occurrence of cardiac arrhythmias in horses with experimentally induced endotoxaemia

293

Cardiac Troponin I and Troponin T: Recent Players in the Field of Myocardial Markers

294

Cardiac troponin I as predictor of major cardiac events in emergency department patients with acute chest pain

295

Cardiac troponin I as a marker for AMI

296

Cardiac troponin I as a marker for severity and prognosis of cardiac disease in dogs

297

Cardiac Troponin I as a Marker of Sepsis Severity and Mortality Prediction

298

Cardiac troponin i as a predictor of respiratory failure in children hospitalized with respiratory syncytial virus (RSV) infections: a pilot study

299

Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction

300

Cardiac Troponin I Elevation in Hospitalized Patients Without Acute Coronary Syndromes

301

Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients

302

Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy

303

Cardiac troponin I in acute coronary ischemic syndromes. Epidemiological and clinical correlates

304

Cardiac troponin i in acute pericarditis

305

Cardiac troponin I in aortic valve disease

306

Cardiac troponin I in neonates undergoing the arterial switch operation

307

Cardiac Troponin I in Patients With Acute Lower Limb Ischemia

308

Cardiac Troponin I Levels Are Normal or Minimally Elevated After Transthoracic Cardioversion

309

Cardiac Troponin I Levels Measured With a High-Sensitive Assay Increase Over Time and Are Strong Predictors of Mortality in an Elderly Population

310

Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences

311

Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock

312

Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage

313

Cardiac troponin I proves less accurate in low-risk cardiac patients

314

Cardiac Troponin I Release After Coronary Artery Bypass Grafting Operation: Effects on Operative and Midterm Survival

315

Cardiac troponin I release after open heart surgery: a marker of myocardial protection?

316

Cardiac troponin I release in acute pulmonary embolism in relation to the duration of symptoms

317

Cardiac troponin I release in heart transplantation

318

Cardiac troponin I release in non-ischemic reversible myocardial injury from acute diphtheric myocarditis

319

Cardiac troponin I release in non-ischemic reversible myocardial injury from parvovirus B19 myocarditis

320

Cardiac troponin I: A potential marker of exercise intolerance in patients with moderate heart failure

321

Cardiac Troponin Increases Among Runners in the Boston Marathon

322

Cardiac Troponin Levels Following Complicated and Uncomplicated Epileptic Seizures

323

Cardiac troponin release in response to transient ST segment depression

324

Cardiac Troponin T (cTnT) in Hemodialysis Patients with Asymptomatic and Symptomatic Atherosclerosis

325

Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention

326

Cardiac troponin T and I, electrocardiographic wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon

327

Cardiac troponin T and myocardial injury during routine cardiac catheterisation in children

328

Cardiac troponin T as a marker for myocardial ischemia in patients seen at the emergency department for acute chest pain, ,

329

Cardiac Troponin T at 96 Hours After Acute Myocardial Infarction Correlates With Infarct Size and Cardiac Function Original Research Article

330

Cardiac troponin T concentration after coronary balloon angioplasty

331

Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality

332

Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes

333

Cardiac Troponin T in Patients With Clinically Suspected Myocarditis

334

Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema

335

Cardiac Troponin T Levels for Risk Stratification in Pediatric Open Heart Surgery

336

Cardiac troponin T levels in umbilical cord blood,

337

Cardiac Troponin T Levels of Umbilical Cord in Neonates with Abnormal Fetal Heart Rate

338

Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T–tropomyosin interaction and causes a Ca2+ desensitization

339

Cardiac Troponin T Release Is Stimulated by Endurance Exercise in Healthy Humans

340

Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting, ,

341

Cardiac Troponin: A Villain or a Decent Actor in the Process of Ongoing Myocardial Injury?

342

Cardiac troponin-I content of skeletal muscle in patients with renal failure

343

Cardiac troponins after a downhill marathon

344

Cardiac troponins and oxidative stress markers in non-pregnant, pregnant and preeclampsia women

345

Cardiac troponins I and T in hemodialysis patients without acute coronary syndrome

346

Cardiac troponins in congestive heart failure, ,

347

Cardiac Troponins in Patients With Chronic Kidney Disease and Kidney Transplant Recipients Without Acute Cardiac Symptoms

348

Cardiac troponins in renal insufficiency: Review and clinical implications

349

Cardiac Troponins in Young Marathon Runners

350

Cardiac Troponins: A Tool for a Personalized Medicine Strategy in Stable Coronary Artery Disease?

351

Cardiac troponins: IT upgrade for the heart

352

Cardiac tuberculoma presenting as thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

353

Cardiac tuberculosis presenting as small intestinal gangrene

354

Cardiac tumor comprising two components including typical myxoma and atypical hypercellularity suggesting a malignant change

355

Cardiac tumor due to Erdheim-Chester disease

356

Cardiac Tumor-Like Mass in a Patient With Systemic Vasculitis

357

Cardiac Tumors and Associated Arrhythmias in Pediatric Patients, With Observations on Surgical Therapy for Ventricular Tachycardia

358

Cardiac Unloading Alters Contractility and Calcium Homeostasis in Ventricular Myocytes

359

Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection Original Research Article

360

Cardiac Uses of Phosphodiesterase-5 Inhibitors

361

Cardiac vagal activity: a target for intervention in heart disease

362

Cardiac vagal control and dynamic responses to psychological stress among patients with coronary artery disease

363

Cardiac vagal control in the severity and course of depression: The importance of symptomatic heterogeneity

364

Cardiac vagal responsiveness during development in spontaneously hypertensive rats

365

Cardiac valve evaluation and adipokine levels in obese women treated with sibutramine

366

Cardiac Valve Granulocytic Sarcoma Infiltration as an Complicating Acute Myelogenous Leukemia: a Case Report

367

Cardiac valve interstitial cells secrete fibronectin and form fibrillar adhesions in response to injury

368

Cardiac Valve Interstitial Cells: Regulator of Valve Structure and Function

369

Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies

370

Cardiac Valve Prostheses at Autopsy: An Analysis of 337 Cases with Clinicopathologic Correlation

371

Cardiac valve replacement in human immunodeficiency virus–infected patients

372

Cardiac valve replacement in patients on dialysis

373

Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival

374

Cardiac valves and valvular pathology: Update on function, disease, repair, and replacement

375

Cardiac Valvular Calcification in Hemodialysis Patients

376

Cardiac valvular vegetations in cancer patients: A prospective echocardiographic study of 200 patients

377

Cardiac Variables as Main Predictors of Endotracheal Reintubation Rate after Cardiac Surgery

378

Cardiac Varix in Relation to Right Atrial Free Wall Presenting as a Mass Compressing the Right Atrium and Mimicking a Pericardial Cyst

379

Cardiac Ventricular Diastolic and Systolic Duration in Children With Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy

380

Cardiac versus noncardiac limits to exercise after heart transplantation, , ,

381

Cardiac Wegener’s granulomatosis masquerading as left atrial myxoma

382

Cardiac Whipple’s disease without digestive symptoms

383

Cardiac Xenotransplantation

384

Cardiac xenotransplantation: clinical experience and future direction

385

Cardiac, pancreatic, and liver abnormalities in a patient with coxsackie-B infection

386

Cardiac-directed expression of adenylyl cyclase reverses electrical remodeling in cardiomyopathy

387

Cardiac-Directed Expression of Adenylyl Cyclase VI Facilitates Atrioventricular Nodal Conduction Original Research Article

388

Cardiac-induced physiologic noise in tissue is a direct observation of cardiac-induced fluctuations

389

Cardiac-specific Abrogation of NF- κ B Activation in Mice by Transdominant Expression of a Mutant Iκ B α

390

Cardiac-specific and ligand-inducible target gene expression in transgenic mice

391

Cardiac-Specific Deletion of SOCS-3 Prevents Development of Left Ventricular Remodeling After Acute Myocardial Infarction

392

Cardiac-specific Gene Expression: a HANDful of Factors

393

Cardiac-specific haploinsufficiency of β-catenin attenuates cardiac hypertrophy but enhances fetal gene expression in response to aortic constriction

394

Cardiac-specific Overexpression of Calsequestrin Results in Left Ventricular Hypertrophy, Depressed Force–frequency Relation and Pulsus Alternans In Vivo

395

Cardiac-specific overexpression of catalase rescues ventricular myocytes from ethanol-induced cardiac contractile defect

396

Cardiac-specific overexpression of Gαq alters excitation–contraction coupling in isolated cardiac myocytes

397

Cardiac-specific overexpression of NCX1.1 mutant induces dilated cardiomyopathy in mice

398

Cardiac-specific Overexpression ofα1BAR RegulatesβAR Activity Via Molecular Crosstalk

399

Cardiac-synchronized gadolinium-enhanced MR angiography: preliminary experience for the evaluation of the thoracic aorta

400

Cardiac-triggered and segmented two-dimensional mr angiography of peripheral arterial occlusive disease: A pictorial essay

401

Cardiacα-adrenergic Receptor Expression is Regulated by Thyroid Hormone During a Critical Developmental Period

402

CARDINAL ARITHMETIC IN THE STYLE OF BARON VON MU¨ NCHHAUSEN

403

Cardinal B-spline dictionaries on a compact interval

404

Cardinal characteristics and projective wellorders

405

Cardinal Characteristics and the Product of Countably Many Infinite Cyclic Groups Original Research Article

406

Cardinal Characteristics and the Product of Countably Many Infinite Cyclic Groups Original Research Article

407

Cardinal characteristics for Menger-bounded subgroups

408

Cardinal directions between spatial objects: the pairwise-consistency problem

409

Cardinal Exponential Splines: Part II—Think Analog, Act Digital.

410

Cardinal Exponential Splines: Part I—Theory and Filtering Algorithms.

411

Cardinal functions of Pixley–Roy hyperspaces

412

Cardinal Interpolating Multiresolutions Original Research Article

413

Cardinal interpolation with polysplines on annuli Original Research Article

414

Cardinal invariants about shrinkability of unbounded sets

415

Cardinal invariants above the continuum Original Research Article

416

Cardinal invariants and -factorizability in paratopological groups

417

Cardinal invariants and independence results in the poset of precompact group topologies Original Research Article

418

Cardinal invariants in locally -minimal paratopological groups

419

Cardinal invariants of monotonically normal spaces

420

Cardinal invariants of the continuum and combinatorics on uncountable cardinals

421

Cardinal invariants related to permutation groups

422

Cardinal limits: Evidence from language awareness and bilingualism for developing concepts of number

423

Cardinal numbers associated with dense pseudocompact, countably compact, and ω-bounded subgroups

424

Cardinal sequences

425

Cardinal sequences of LCS spaces under GCH

426

Cardinal Series Interpolation to Nonuniform Grids Original Research Article

427

Cardinal temperatures for germination of Kochia scoparia (L.)

428

Cardinal transfer properties in extender models

429

Cardinal vein isomerism: An embryological hypothesis to explain a persistent left superior vena cava draining into the roof of the left atrium in the absence of coronary sinus and atrial septal defect

430

Cardinalities in depth: a formal approach to partial validation of conceptual schema

431

Cardinalities of ccc-spaces with regular -diagonals

432

Cardinalities of k-distance sets in Minkowski spaces Original Research Article

433

Cardinalities of some Lindelöf and ω1-Lindelöf T1/T2-spaces

434

Cardinality and the borda score

435

Cardinality Approach to Fuzzy Number Arithmetic

436

Cardinality bounds for subdirectly irreducible algebras Original Research Article

437

Cardinality concepts for type-two fuzzy sets

438

Cardinality constrained Boolean quadratic polytope Original Research Article

439

Cardinality constrained minimum cut problems: complexity and algorithms Original Research Article

440

Cardinality, quantifiers, and the aggregation of fuzzy criteria

441

Cardinality-restricted chains and antichains in partially ordered sets Original Research Article

442

Cardio Navigation: Planning, Simulation, and Augmented Reality in Robotic Assisted Endoscopic Bypass Grafting

443

Cardio protective effect of Coriandrum sativum L. on isoproterenol induced myocardial necrosis in rats

444

Cardioactive steroid poisoning from an herbal cleansing preparation

445

Cardioameliorative effect of punicalagin against streptozotocin-induced apoptosis, redox imbalance, metabolic changes and inflammation

446

Cardio-ankle vascular index may be an important marker of silnt neuronal injury after percutaneous coronary angiography and intervention: a prospective observational study on diagnostic accuracy

447

Cardiobacterium hominis endocarditis presenting as acute embolic stroke: A case report and review of the literature

448

Cardiocerebral Resuscitation for Cardiac Arrest

449

Cardiocerebral Resuscitation Improves Survival of Patients with Out-of-Hospital Cardiac Arrest

450

Cardiocerebral Resuscitation: A Broader Perspective

451

Cardiocerebral resuscitation: advances in cardiac arrest resuscitation

452

Cardio-cerebrovascular complications in elderly with diabetes

453

Cardio-Cerebrovascular Protective Effects of Valsartan in High-Risk Hypertensive Patients With Coronary Artery Disease (from the Kyoto Heart Study)

454

Cardiocyte cytoskeleton in patients with left ventricular pressure overload hypertrophy

455

Cardiodepressant Effects of Interferon-γand Endotoxin Reversed by Inhibition of NO Synthase 2 in Rat Myocardium

456

Cardiodepressive Mediators Are Released After Ischemi From an Isolated Heart: Role of Coronary Endothelial Cells

457

Cardioembolic Source of ST-Segment Elevation Myocardial Infarction

458

Cardioembolic Stroke

459

Cardioembolic stroke: an update

460

Cardioesophageal reflex: mechanism for “linked angina” in patients with angiographically proven coronary artery disease

461

Cardio-facio-cutaneous syndrome and moyamoya syndrome

462

Cardiogel as an Instructive Microenvironment for in vitro Differentiation of Bone Marrow Derived Mesenchymal Stem Cells into Cardiomyocytes

463

Cardiogenic and Aortogenic Brain Embolism Review Article

464

Cardiogenic shock

465

Cardiogenic shock

466

Cardiogenic Shock and Anterior Papillary Muscle Rupture Caused by Blood Supply to Diagonal Artery

467

cardiogenic shock and anterior papillary muscle rupture caused by blood supply to diagonal artery

468

Cardiogenic shock at admission in patients with multivessel disease and acute myocardial infarction treated with percutaneous coronary intervention: Related factors

469

Cardiogenic shock caused by right ventricular infarction: A report from the SHOCK registry

470

Cardiogenic shock caused by simultaneous subacute stent thrombosis after implantation of sirolimus-eluting stents

471

Cardiogenic shock complicating acute carbon monoxide poisoning despite neurologic and metabolic recovery

472

Cardiogenic shock complicating acute coronary syndromes

473

Cardiogenic shock complicating acute myocardial infarction in California: effect of invasive procedures on mortality

474

Cardiogenic shock complicating acute myocardial infarction in elderly patients: Does admission to a tertiary center improve survival?

475

Cardiogenic shock complicating acute myocardial infarction: Predictors of death

476

Cardiogenic shock complicating acute myocardial infarction—etiologies, management and outcome: a report from the SHOCK Trial Registry

477

Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry

478

Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry

479

Cardiogenic shock due to coronary narrowings one day after a MAZE III procedure

480

Cardiogenic shock due to myocardial infarction caused by coronary vasospasm associated with hyperthyroidism

481

Cardiogenic Shock due to Psychosis-Induced Inverted Takotsubo Cardiomyopathy Bridged-to-Recovery with a Percutaneous Left Ventricular Assist Device

482

Cardiogenic shock following electro-cardioversion of new onset atrial flutter

483

Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption

484

CARDIOGENIC SHOCK IN ADULT PATIENTS WITH NON-ST ELEVATION MYOCARDIAL INFARCTION

485

Cardiogenic shock with non-ST-segment elevation myocardial infarction: a report from the SHOCK Trial Registry

486

Cardiogenic Shock Without Flow-Limiting Angiographic Coronary Artery Disease—(from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry)

487

Cardiogenic shock: Basics and clinical considerations

488

Cardiogenic Shock: Collaboration Between Cardiac Surgery and Cardiology Subspecialties to Bridge to Recovery

489

Cardiogenic shock: is there light at the end of the tunnel?

490

Cardiographic conundrum: Adding insult to injury

491

Cardiohepatic Interactions in Heart Failure: An Overview and Clinical Implications

492

Cardioinhibitory syncope due to bloodphobia associated asystole

493

Cardiolinka bohemica (Barrande, 1881) – A first representative of the Late Silurian Bohemian type Bivalvia fauna from the northern Arabian Plate, Southeast Turkey

494

Cardiolipin Clusters and Membrane Domain Formation Induced by Mitochondrial Proteins

495

Cardiolipin deficiency leads to decreased cardiolipin peroxidation and increased resistance of cells to apoptosis

496

Cardiolipin Enhances Protein C Pathway Anticoagulant Activity,

497

Cardiologic and neurologic findings in left ventricular hypertrabeculation/noncompaction relating to echocardiographic indication

498

Cardiological applications of nuclear medicine Review Article

499

Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome

500

Cardiologist Concordance With the American College of Cardiology Appropriate Use Criteria for Cardiac Testing in Patients With Coronary Artery Disease

501

Cardiologist in the carotids

502

Cardiologist in the dugout

503

Cardiologist in the Land of the Thunder Dragon: A Medical Mission to Bhutan

504

Cardiologist on trial: reflections on credible evidence

505

Cardiologist versus internist management of patients with unstable angina: Treatment patterns and outcomes

506

Cardiologist’s Role in Improving Glucose Control and Global Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus

507

Cardiologists Knowledge and Attitudes About Methadone and Buprenorphine Maintenance Treatment: A Survey Study in Tehran, Iran

508

Cardiologistsʹ discussions about sexuality with patients with chronic coronary artery disease

509

Cardiologists in casualty?

510

Cardiologistsʹ knowledge of the 2005 American Heart Association Resuscitation Guidelines: The Athens Study

511

Cardiologistsʹ practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarction

512

Cardiologists recommend Fragmin

513

Cardiologists versus internists in the care of unstable angin

514

Cardiologists, the PINNACLE Registry, and the “Meaningful Use” of Electronic Health Records

515

Cardiologists’ Knowledge and Perception towards American Heart Association Guidelines of Cardiopulmonary Resuscitation; a Letter to Editor

516

Cardiologists’ Perception of Risk of Coronary Revascularization Procedures

517

Cardiology 2010, 13th Annual Update on Pediatric Cardiovascular Disease: Abstracts

518

Cardiology and emergency medicine: United We Stand, divided we fall

519

Cardiology and neurologic family screening in noncompaction

520

Cardiology and the Critical Care Crisis: A Perspective Review Article

521

Cardiology in a Flat World

522

Cardiology in cattle: Knowledge and expertise are the sine qua non for optimal economic medicine

523

Cardiology in contemporary China: An update

524

Cardiology in India

525

Cardiology in India: State of the Art or Straight off the Heart?

526

Cardiology in South America

527

Cardiology Integration: Challenge and Opportunity

528

Cardiology management improves secondary prevention measures among patients with coronary artery disease Original Research Article

529

Cardiology participation improves outcomes in patients with new-onset heart failure in the outpatient setting

530

Cardiology rounds

531

Cardiology screening on the net

532

Cardiology Workforce Crisis: Shortage or Surplus?

533

Cardiology Workforce Revisited

534

Cardiology workforce: there’s already a shortage, and it’s getting worse!

535

Cardiology, for what itʹs worth

536

Cardiology: “Itʹs small world after all”

537

Cardiology: a call for papers

538

Cardiology: American Journal of Medicine theme issue

539

Cardiology: call for papers

540

Cardiology: the past, the present, and the future

541

Cardiology: where to go from here?

542

Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure

543

Cardiomegaly in a young infant

544

Cardiometabolic Abnormalities in Current National Football League Players

545

Cardiometabolic Consequences of Gestational Dysglycemia

546

Cardiometabolic Risk and Cognitive Function Decline in U.S. Elderly

547

Cardiometabolic Risk Factors in Fructose-Induced Insulin Resistant Rats: Comparative Effects of Palm and Olive Oils

548

Cardio-metabolic risk factors in Iranian children: where we are and the others?

549

Cardiometabolic risk factors in polycystic ovary syndrome

550

Cardiomodulating Activity of Gongronema latifolium and Lisinopril in Doxorubicin-induced Cardiotoxicity in Wistar Rats

551

Cardiomyocyte Apoptosis After Antegrade and Retrograde Cardioplegia

552

Cardiomyocyte apoptosis and ischemic preconditioning in open heart operations

553

Cardiomyocyte apoptosis in cocaine-induced myocarditis with involvement of bundle of His and left bundle branch

554

Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis

555

Cardiomyocyte death and renewal in the normal and diseased heart

556

Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death Strategies

557

Cardiomyocyte Hypertrophy, Oncosis, and Autophagic Vacuolization Predict Mortality in Idiopathic Dilated Cardiomyopathy With Advanced Heart Failure

558

Cardiomyocyte Injury Assessed by a Highly Sensitive Troponin Assay and Sudden Cardiac Death in the Community: The Cardiovascular Health Study

559

Cardiomyocyte Marker Expression in Mouse Embryonic Fibroblasts by Cell-Free Cardiomyocyte Extract and Epigenetic Manipulation

560

Cardiomyocyte Mitochondrial Dynamics in Health and Disease and the Role of Exercise Training: A Brief Review

561

Cardiomyocyte proteome 2-D gel database construction: Detection and identification of co-migrating proteins

562

Cardiomyocyte Resistance to Doxorubicin Mediated by A3 Adenosine Receptor

563

Cardiomyocyte resistance to doxorubicin toxicity may be achieved by adenosine signaling

564

Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction

565

Cardiomyocyte Transplantation Improves Heart Function

566

Cardiomyocyte-restricted deletion of connexin43 during mouse development

567

Cardiomyocytes from hearts with left ventricular dysfunction after ischemia-reperfusion do not manifest contractile abnormalities

568

Cardiomyocytes morphologic and metabolic response to angiotensin II is mediated by NFκB-induced inactivation of PPAR isoforms

569

Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium

570

Cardiomyocytes β-adrenergic receptors are resistants to short-term desensitization

571

Cardiomyocyte-Specific Deletion of Gsk3α Mitigates Post–Myocardial Infarction Remodeling, Contractile Dysfunction, and Heart Failure

572

Cardiomyocyte-specific desmin rescue of desmin null cardiomyopathy excludes vascular involvement

573

Cardiomyocyte-targeted siRNA delivery by prostaglandin E2-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis

574

Cardiomyogenic potential of skeletal muscle-derived progenitor cells

575

Cardiomyogenic stem and progenitor cell plasticity and the dissection of cardiopoiesis

576

Cardiomyopathic lentiginosis: an echo-Doppler report

577

Cardiomyopathies: from genetics to the prospect of treatment

578

CARDIOMYOPATHIES: PRESENTATION AND COMPLICATIONS IN CHILDREN AT DERA ISMAIL KHAN

579

Cardiomyopathy and Myopathy in Left Ventricular Noncompaction

580

Cardiomyopathy Due to Nonsustained Ventricular Tachycardia Originating from the Aortic Sinus Cusp

581

Cardiomyopathy in a Male with Cystinosis

582

Cardiomyopathy in childhood, mitochondrial dysfunction, and the role of L-carnitine

583

Cardiomyopathy in Danish patients with coeliac disease

584

Cardiomyopathy in infancy and postmortem di diagnosis of a fatty acid oxidation defect

585

Cardiomyopathy in neurological disorders

586

CARDIOMYOPATHY IN PATIENTS INFECTED WITH HUMAN IMMUNE DEFICIENCY VIRUS.

587

Cardiomyopathy in rats with Walker 256 tumor: The potential role of microvascular disease in its genesis

588

Cardiomyopathy with a unique finding of bicuspid aortic valve in Beckerʹs muscular dystrophy

589

Cardiomyopathy with Pancytopenia in a Pregnancy: Case Reports

590

Cardiomyopathy, nephropathy, and death in a 44-year-old man

591

Cardiomyopathy: a role for nitric oxide?

592

Cardiomyoplasty — Improvement of Muscle Fibre Type Transformation by an Anabolic Steroid (Metenolone)

593

Cardiomyoplasty after implantation of a pacemaker and cardioverter/defibrillator

594

Cardiomyoplasty reduces myocardial oxygen consumption: implications for direct mechanical compression

595

Cardiomyoplasty: Is it time to wrap it up?

596

Cardiomyoplasty: the benefits of electrical prestimulation of the latissimus dorsi muscle in situ

597

Cardio-Oesophageal Reflex: Mechanism for “Linked Angina” in Patients with Angiographically Proven Coronary Artery Disease

598

Cardio-Oncology in Iran: Cardio-toxicity Registry

599

Cardiopetalolactone: A Novel Styryllactone from Goniothalamus cardiopetalus

600

Cardioplegia and Diazoxide Modulate STAT3 Activation and DNA Binding

601

Cardioplegia and ischemia in the canine heart evaluated by 31P magnetic resonance spectroscopy

602

Cardioplegia in pediatric cardiac surgery: do we believe in magic?

603

Cardioplegia preserves hypoxic response in isolated coronary arteries but not in isolated hearts

604

Cardioplegia protection against ischemia-reperfusion failure: Role of both modes of Na/Ca-exchanger and sarcoplasmic reticulum

605

Cardioplegia-induced cell swelling: prevention by normothermic infusion

606

Cardioplegic arrest with image-arginine improves myocardial protection: results of a prospective randomized clinical trial

607

Cardioplegic ischemia or reperfusion: Which is a main trigger for tumor necrosis factor production?

608

Cardiopoiesis: Cardiac myocyte creation by adult and embryonic cells

609

Cardiopoietic Stem Cell Therapy in Heart Failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) Multicenter Randomized Trial With Lineage-Specified Biologics

610

Cardiopoietry in Motion: Primed Mesenchymal Stem Cells for Ischemic Cardiomyopathy

611

Cardioprotection and garlic

612

Cardioprotection and garlic

613

Cardioprotection and garlic

614

Cardioprotection and garlic

615

Cardioprotection and mitochondrial S-nitrosation: Effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia–reperfusion injury

616

Cardioprotection at a Distance: Mesenteric Artery Occlusion Protects the Myocardium via an Opioid Sensitive Mechanism

617

Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriers

618

Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger

619

Cardioprotection by Activation of NO/cGMP Pathway After Cardioplegic Arrest and 8-Hour Storage

620

Cardioprotection by Cyclosporine A in Experimental Ischemia and Reperfusion—Evidence for a Nitric Oxide-dependent Mechanism Mediated by Endothelin

621

Cardioprotection by Ischemic Preconditioning Preserves Mitochondrial Function and Functional Coupling Between Adenine Nucleotide Translocase and Creatine Kinase

622

Cardioprotection by Local Heating: Improved Myocardial Salvage After Ischemia and Reperfusion

623

Cardioprotection by Orotic Acid: Metabolism and Mechanism of Action

624

Cardioprotection by Volatile Anesthetics in Noncardiac Surgery? No, Not Yet At Least

625

Cardioprotection During Chemotherapy: Need for Faster Transfer of Knowledge From Cardiology to Oncology and Role for a Cardio-Oncologist

626

Cardioprotection Effects of Sevoflurane by Regulating the Pathway of Neuroactive Ligand-Receptor Interaction in Patients Undergoing Coronary Artery Bypass Graft Surgery

627

Cardioprotection for Duchenne’s muscular dystrophy, ,

628

Cardioprotection from ischaemia–reperfusion injury: Dissecting the PI3K/AKT pathway with chemical inhibition of PTEN

629

Cardioprotection in aged myocardium: Sites of failure in protective signalling

630

Cardioprotection induced in response to preconditioning is lost after an initral iscraemic insult

631

Cardioprotection of bradykinin at reperfusion in isolated rat hearts requires a transactivation of the EGF receptor

632

Cardioprotection of trimetazidine and anthracycline-induced acute cardiotoxic effects

633

Cardioprotection with phosphodiesterase-5 inhibition—a novel preconditioning strategy

634

Cardioprotection: A New Paradigm in the Management of Acute Heart Failure Syndromes

635

Cardioprotection: Intermittent Ventricular Fibrillation and Rapid Pacing Can Induce Preconditioning in the Blood-perfused Rat Heart

636

Cardioprotective Actions of Verapamil on theβ-Adrenergic Receptor Complex in Acute Canine Chagasʹ Disease

637

Cardioprotective activity of melatonin and its novel synthesized derivatives on doxorubicin-induced cardiotoxicity Original Research Article

638

Cardio-protective and anti-cancer therapeutic potential of Nigella sativa

639

Cardioprotective and antioxidant activities of a polysaccharide from the root bark of Aralia elata (Miq.) Seem

640

Cardioprotective and Anti-oxidant Effects of the Terpenoid Constituents ofGinkgo bilobaExtract (EGb 761)

641

Cardio-protective and cholesterol lowering effects of garlic (Allium sativum) and ginger (Zingiber officiale) extracts in laboratory animals

642

Cardioprotective and Hepatoprotective Activity of Silymarin in Broiler Chickens Fed on Mash and Pellet Diets

643

Cardioprotective and neuroprotective roles of oleuropein in olive

644

Cardioprotective and neuroprotective roles of oleuropein in olive

645

Cardioprotective Effect by Tumor Necrosis Factor-α and Interleukin-6 through Late Preconditioning in Unstable Angina Patients

646

Cardioprotective effect of aqueous extract of Chichorium intybus L. on ischemia-reperfusion injury in isolated rat heart

647

Cardioprotective effect of Azadirachta indica A. Juss. on isoprenaline induced myocardial infarction in rats

648

Cardioprotective Effect of Beta-3 Adrenergic Receptor Agonism: Role of Neuronal Nitric Oxide Synthase

649

Cardioprotective effect of cedrol in an inflammation systemic model induced by lipopolysaccharide: Biochemical and histological verification

650

Cardioprotective effect of chronic hypoxia is blunted by hypercapnia

651

Cardioprotective effect of chronic low dose ethanol drinking: Insights into the concept of ethanol preconditioning

652

Cardioprotective Effect of Cold-Blood Cardioplegia Enriched with N-Acetylcysteine During Coronary Artery Bypass Grafting

653

Cardioprotective effect of diazepam on ischemia-reperfused isolated hyperthyroid rat heart

654

Cardioprotective Effect of Ethanolic Leaf Extract of Melissa Officinalis L Against Regional Ischemia-Induced Arrhythmia and Heart Injury after Five Days of Reperfusion in Rats

655

Cardioprotective Effect of Extended Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Clinical Trial

656

Cardioprotective effect of fasting on ischemia reperfused rat heart after diazepam administration

657

Cardioprotective Effect of Garlic Juice on the Isolated Rat Heart in Ischemia- Reperfusion

658

Cardioprotective Effect of Glucagon Like Peptide-1 Receptor During Reperfusion of Isolated Ischemic Rat Heart Involves AMP-Activated Protein Kinase (AMPK) and Akt Signaling Pathways

659

Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats

660

Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats

661

Cardioprotective effect of growth hormone secretagogues in rat heart

662

Cardioprotective Effect of High Intensity Interval Training and Nitric Oxide Metabolites (NO2-, NO3-)

663

Cardioprotective Effect of High-Intensity Aerobic Interval Training against Adriamycin-Induced Cardiac Toxicity in Rats

664

Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats

665

Cardioprotective effect of lipstatin derivative orlistat on normotensive rats submitted to cardiac ischemia and reperfusion

666

Cardioprotective effect of preconditioning is more efficient than postconditioning in rats submitted to cardiac ischemia and reperfusion

667

Cardioprotective Effect of Quercetin against Ischemia/Reperfusion Injury Is Mediated Through NO System and Mitochondrial KATP Channels

668

Cardioprotective effect of Rosa canina L. methanolic extract on heat shock induced cardiomyocyte injury: An experimental study

669

Cardioprotective effect of royal jelly on paclitaxel-induced cardio-toxicity in rats

670

Cardioprotective Effect of Saffron Extract and Safranal in Isoproterenol-Induced Myocardial Infarction in Wistar Rats

671

Cardioprotective effect of selenium via modulation of cardiac ryanodine receptor calcium release channels in diabetic rat cardiomyocytes through thioredoxin system

672

Cardioprotective effect of vanillic acid against doxorubicin-induced cardiotoxicity in rat

673

CARDIOPROTECTIVE EFFECTS AND MECHANISM OF ACTION OF POLYPHENOLS EXTRACTED FROM PROPOLIS AGAINST DOXORUBICIN TOXICITY

674

Cardioprotective effects and molecular mechanisms of G-CSF on LV remodeling and dysfunction after AMI

675

Cardioprotective Effects of 17β-Estradiol Produced by Activation of Mitochondrial ATP-Sensitive K+Channels in Canine Hearts

676

Cardioprotective effects of a proanthocyanidin-rich fraction from Croton celtidifolius Baill: Focus on atherosclerosis

677

Cardioprotective effects of an early invasive strategy for non–ST-segment elevationacute coronary syndromes: Are we all becoming “interventional” cardiologists?

678

Cardioprotective effects of atorvastatin plus trimetazidine in percutaneous coronary intervention

679

Cardioprotective effects of bosentan, a mixed ETA/ETB Receptor antagonist on myocardial ischemic and reperfusion injury in cats

680

Cardioprotective effects of co-administration of thymoquinone and ischemic postconditioning in diabetic rats

681

Cardioprotective Effects of Coenzyme Q10 Supplementation on Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

682

Cardioprotective Effects of Curcumin Co-treatment in Rats With Establishing Chronic Variable Stress Stereology Study

683

Cardioprotective Effects of Essential Oil of Lavandula angustifolia on Isoproterenol-induced Acute Myocardial Infarction in Rat

684

Cardioprotective effects of Fenugreek (Trigonella foenum-graceum) seed extract in streptozotocin induced diabetic rats

685

Cardioprotective effects of FK409, a nitric oxide donor, after isolated rat heart preservation for 16 hours

686

Cardioprotective effects of Ganoderma lucidum on isoproterenol–induced heart failure

687

Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia

688

Cardioprotective Effects of Granulocyte Colony-Stimulating Factor in Swine With Chronic Myocardial Ischemia Original Research Article

689

Cardioprotective Effects of Grape Seed Proanthocyanidin Against Ischemic Reperfusion Injury

690

Cardioprotective effects of Ilex paraguariensis extract: evidence for a nitric oxide-dependent mechanism

691

Cardioprotective effects of iroxanadine: Role of nitric oxide, reactive oxygen species and heat-shock proteins

692

cardioprotective effects of mebudipine in a rat model of doxorubicin-induced heart failure

693

Cardioprotective Effects of Methanolic Extract of Scrophularia frigida on Ischemia-Reperfusion-Induced Injuries in Isolated Rat Heart

694

cardioprotective effects of octreotide against sepsis-induced cardiotoxicity in mice

695

Cardioprotective effects of pharmacologic preconditioning by natural honey against ischemia/reperfusion injury

696

Cardioprotective effects of pomegranate juice against ischemia and reperfusion in isolated rat heart

697

Cardioprotective Effects of Potassium Channel Openers on Rat Atria and Isolated Hearts under Acute Hypoxia

698

Cardioprotective effects of preinfarction angina in elderly: same patients, different results?

699

Cardioprotective Effects of Rosmarinic Acid on IsoproterenolInduced Myocardial Infarction in Rats

700

Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention

701

Cardioprotective effects of the NHE1-inhibitor EMD 87580

702

Cardioprotective efficacy of ischemic preconditioning on long-term myocardial ischemia

703

Cardioprotective Function of Inducible Nitric Oxide Synthase and Role of Nitric Oxide in Myocardial Ischemia and Preconditioning: an Overview of a Decade of Research

704

Cardioprotective mechanisms of sour cherry seed extract against ischemia/reperfusion-induced damage in isolated rat hearts

705

Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial Disease Original Research Article

706

Cardioprotective Potential of Antihypertensives

707

Cardioprotective potential of biobased gold nanoparticles

708

Cardioprotective Potential of Celastrol in Sepsis-Induced Cardiotoxicity; Mouse Model of Endotoxemia

709

Cardioprotective Potential of Gemmomodified Extract of Terminalia arjuna against Chemically Induced Myocardial Injury in Rabbits

710

Cardio-protective properties of Momordica charantia in Albino Rats

711

Cardioprotective role of biosynthesized gold nanoparticles compared to an iodinated-based x-ray contrast agent in Male Wistar Rats

712

Cardioprotective role of FGF2 in a murine model of low-flow ischemia

713

Cardio-Protective Role of Gingerol along with Prominent Anti-Diabetic Cardiomyopathy Action in A Streptozotocin-Induced Diabetes Mellitus Rat Model StreptozotocinInduced Diabetes Mellitus Rat Model

714

Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals

715

Cardiopulmonary and Systemic Effects of Methylprednisolone in Patients Undergoing Cardiac Surgery

716

Cardiopulmonary Arrest Outcome in Nemazee Hospital, Southern Iran

717

CARDIOPULMONARY ARREST SECONDARY TO HALOPERIDOL

718

CARDIO-PULMONARY ASSESSMENT IN PATIENTS WITH BETA THALASSEMIA

719

Cardiopulmonary bypass affects cognitive brain function after coronary artery bypass grafting

720

Cardiopulmonary Bypass Alone Does Not Cause Postoperative Cognitive Dysfunction Following Open Heart Surgery

721

Cardiopulmonary bypass alters vasomotor regulation of the skeletal muscle microcirculation

722

Cardiopulmonary bypass and oxygen consumption: oxygen delivery and hemodynamics

723

Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans

724

Cardiopulmonary Bypass Circuit Treated With Surface-Modifying Additives: A Clinical Evaluation of Blood Compatibility

725

Cardiopulmonary bypass during pregnancy

726

Cardiopulmonary bypass for resuscitation after penetrating cardiac trauma

727

Cardiopulmonary bypass in a gravid patient: perioperative changes in endothelin levels

728

Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant

729

Cardiopulmonary bypass in humans: bypassing unfractionated heparin

730

Cardiopulmonary bypass in man: role of the intestine in a self-limiting inflammatory response with demonstrable bacterial translocation

731

Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis

732

Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using org 10172

733

Cardiopulmonary bypass in pregnancy

734

Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases

735

Cardiopulmonary bypass perfusion temperature does not influence perioperative renal function

736

Cardiopulmonary bypass support for emergency cesarean delivery in a patient with severe pulmonary hypertension

737

Cardiopulmonary bypass temperature, hematocrit, and cerebral oxygen delivery in humans

738

Cardiopulmonary Bypass Time Does Not Affect Cerebral Blood Flow

739

Cardiopulmonary Bypass With Bivalirudin in Type II Heparin-Induced Thrombocytopenia

740

Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia

741

Cardiopulmonary Bypass With Heparin-Coated Circuits and Reduced Systemic Anticoagulation

742

Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions

743

Cardiopulmonary bypass, rewarming, and central nervous system dysfunction

744

Cardiopulmonary bypass: Perioperative cerebral blood flow and postoperative cognitive deficit

745

Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital

746

Cardiopulmonary effects of Detomidine-Propofol and Ketamine administration in the Donkeys

747

Cardiopulmonary effects of dorsal recumbency and high-volume caudal epidural anaesthesia with lidocaine or xylazine in calves

748

Cardiopulmonary effects of HI-6 treatment in soman intoxication

749

Cardiopulmonary effects of the anesthesia by romifidine as a premedication, midazolam and ketamine induction and infusion in donkeys

750

Cardiopulmonary effects of the laparoscopic pneumoperitoneum in a porcine model of adult respiratory distress syndrome

751

Cardiopulmonary exercise parameters in relation to all-cause mortality in patients with chronic heart failure

752

Cardiopulmonary exercise test evidence of isolated right coronary artery disease

753

Cardiopulmonary Exercise Test in Advanced Heart Failure Among Heart Transplantation Candidates

754

Cardiopulmonary exercise test in patients with subacute pulmonary emboli

755

Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited

756

Cardiopulmonary Exercise Testing and Six-Minute Walk Correlations in Pulmonary Arterial Hypertension

757

Cardiopulmonary exercise testing before and one year after mitral valve repair for severe mitral regurgitation

758

Cardiopulmonary Exercise Testing Determination of Functional Capacity in Mitral Regurgitation: Physiologic and Outcome Implications Original Research Article

759

Cardiopulmonary Exercise Testing Identifies Low Risk Patients With Heart Failure and Severely Impaired Exercise Capacity Considered for Heart Transplantation

760

Cardiopulmonary exercise testing in patients with heart failure

761

Cardiopulmonary Exercise Testing in the Clinical and Prognostic Assessment of Diastolic Heart Failure Original Research Article

762

Cardiopulmonary Exercise Variables in Diastolic Versus Systolic Heart Failure

763

Cardiopulmonary Function at Rest and During Exercise After Resection for Bronchial Carcinoma

764

Cardiopulmonary function in adult patients late after Fontan repair

765

Cardiopulmonary Functions of School Children in Oil-Spilled and Gas-Flared Niger- Delta and Rural-Riverine Lagos Communities

766

Cardiopulmonary hazards of perihepatic packing for major liver injuries,

767

Cardiopulmonary helminth parasites of red foxes (Vulpes vulpes) in Catalonia, northeastern Spain

768

Cardiopulmonary Limited Ultrasound Examination for “Quick-Look” Bedside Application

769

Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution

770

Cardiopulmonary Mortalities and Chronic Obstructive Pulmonary Disease Attributed to Ozone Air Pollution

771

Cardiopulmonary mortality and air pollution

772

Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide

773

Cardiopulmonary Rehabilitation for Patients with Coronavirus Disease 2019 (COVID-19): A Narrative Review

774

Cardiopulmonary Response to Exercise and Cardiac Assessment in Patients With Turner Syndrome

775

Cardiopulmonary response to maximal exercise in young athletes following the Ross procedure

776

Cardiopulmonary Responses to Exercise and Its Utility in Patients With Aortic Stenosis

777

Cardiopulmonary responses to robotic end-effector-based walking and stair climbing

778

Cardiopulmonary Resuscitation (CPR) and Its Ethical Aspects

779

CARDIOPULMONARY RESUSCITATION : THE SHORT COMINGS IN MALAYSIA

780

Cardiopulmonary resuscitation and neurological complications in the elderly

781

Cardiopulmonary resuscitation by bystanders with chest compression only (SOS-KANTO): an observational study

782

Cardiopulmonary resuscitation by Emergency Medical Services in South Africa: Barriers to achieving high quality performance

783

Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study

784

Cardiopulmonary resuscitation in nursing homes

785

CARDIOPULMONARY RESUSCITATION IN THE LIGHT OFNEW 2010 AMERICAN HEART ASSOCIATION GUIDELINES: A SURVEY AMONG HEALTHCARE PROFESSIONALS OF TERTIARY CARE HOSPITALS IN PESHAWAR CITY

786

Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire study

787

Cardiopulmonary resuscitation knowledge among nursing students: a questionnaire-based study

788

Cardiopulmonary Resuscitation Outcomes of Patients with COVID-19; a One-Year Survey

789

Cardiopulmonary Resuscitation Techniques and Instruction: When Does Evidence Justify Revision?, ,

790

Cardiopulmonary Resuscitation to Cardiocerebral Resuscitation: Difference Is Small for Statistical Significance but Large for Clinical Relevance

791

cardiopulmonary resuscitation training for medical students in anesthesiology rotation in ardabil medical university (iran)

792

Cardiopulmonary resuscitation with a novel chest compression device in a porcine model of cardiac arrest: Improved hemodynamics and mechanisms Original Research Article

793

Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis

794

Cardiopulmonary Resuscitation, Chest Compression Only and Teamwork From the Perspective of Medical Doctors, Surgeons and Anesthesiologists

795

Cardiopulmonary resuscitation, ventilation, defibrillation: In what order?

796

Cardiopulmonary Resuscitation.J.P. Ornato and M.A. Peberdy, Editors, Humana Press (2005) 764 pages, $185 ISBN 1-58829-283-5.

797

Cardiopulmonary resuscitation: Historical perspective to recent investigations

798

Cardiopulmonary resuscitation: Knowledge and personal experience among dentists in Udaipur, India

799

Cardiopulmonary Safety of Propofol Versus Midazolam/Meperidine Sedation for Colonoscopy: A Prospective, Randomized, Double-Blinded Study

800

Cardiopulmonary-Cerebral Resuscitation (CPCR) Training for Nurses in Iran: A Review Study

801

Cardiorenal and sympathetic effects of leptin in spontaneously hypertensive lean and obese koletsky rats

802

Cardiorenal Anemia Syndrome as a Prognosticator for Death in Heart Failure

803

Cardiorenal Effects of Recombinant Human Natriuretic Peptides

804

Cardiorenal Interactions: Insights From the ESCAPE Trial Original Research Article

805

Cardiorenal Outcomes After Slow Continuous Ultrafiltration Therapy in Refractory Patients With Advanced Decompensated Heart Failure

806

Cardio-Renal Profiling with hs-CRP and its Implications as a Diagnostic Tool in Chronic Kidney Disease Patients.

807

Cardiorenal Protective Effects of Year-Long Antihypertensive Therapy With a Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker in Spontaneously Hypertensive Rats

808

Cardiorenal Syndrome

809

Cardiorenal syndrome

810

Cardiorenal Syndrome Review Article

811

Cardiorenal syndrome followed by acute hepatitis C in a patient with acute myeloid leukemia

812

Cardiorenal Syndrome or Renocardiac Syndrome

813

Cardiorenal Syndrome Type 1: Pathophysiological Crosstalk Leading to Combined Heart and Kidney Dysfunction in the Setting of Acutely Decompensated Heart Failure

814

Cardio-renal-anemia syndrome: a report of three cases

815

Cardiorespiratory and all-cause mortality after restrictions on sulphur content of fuel in Hong Kong: an intervention study

816

Cardiorespiratory and neuroendocrine changes induced by methadone in conscious and in isoflurane anaesthetised dogs

817

Cardiorespiratory and thermoregulatory effects of endophyte-infected fescue in exercising horses

818

Cardiorespiratory challenges in Rettʹs syndrome

819

Cardiorespiratory changes during upper gastrointestinal endoscopy

820

Cardio-respiratory control during early development in the model animal zebrafish

821

Cardio-respiratory coupling in untreated patients with major depression

822

CARDIORESPIRATORY CRISIS AT THE END OF PREGNANCY: A CASE OF PHEOCHROMOCYTOMA

823

Cardiorespiratory effects of epidurally administered ketamine or lidocaine in dogs undergoing ovariohysterectomy surgery: a comparative study

824

Cardiorespiratory Fitness and Body Composition of Soccer Referees; Do These Correlate With Proper Performance?

825

Cardiorespiratory fitness and coronary heart disease risk factor association in women

826

Cardiorespiratory Fitness and Its Relationship with Health Risk Factors Among University Students: A Comparison Between Iran and Italy

827

Cardiorespiratory Fitness and Metabolic Risk

828

Cardiorespiratory Fitness and Physical Literacy: Exploring the Nexus. A Scoping Review

829

Cardiorespiratory Fitness and Risk of Nonfatal Cardiovascular Disease in Women and Men With Hypertension

830

Cardiorespiratory fitness and risk of prostate cancer: Findings from the Aerobics Center Longitudinal Study

831

Cardiorespiratory Fitness and the Attenuation of Age-Related Rise in Blood Pressure: An Important Role for Effective Primordial Prevention

832

Cardiorespiratory Fitness as a Correlate of Cardiovascular, Anthropometric, and Physical Risk Factors: Using the Ruffier Test as a Template

833

Cardiorespiratory Fitness as Criterion Validity for Health-Based Metabolic Syndrome Definition in Adolescents

834

Cardiorespiratory Fitness Is Related to the Risk of Sudden Cardiac Death: A Population-Based Follow-Up Study

835

Cardio-respiratory fitness markers among Kenyan university students using a 20m shuttle run test (SRT)

836

Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men

837

Cardiorespiratory Parameters in Intermittent Positive Pressure Ventilation Versus Spontaneous Ventilation in Under One-Year-Old Pediatrics: A Randomized Trial

838

Cardiorespiratory reflexes in a working heart–brainstem preparation of the house musk shrew, Suncus murinus

839

Cardiorespiratory response during exercise in patients with cyanotic congenital heart disease with and without a Fontan operation and in patients with congestive heart failure

840

Cardiorespiratory Response to Exercise After Modified Fontan Operation: Determinants of Performance

841

Cardiorespiratory Response to Exercise After Renal Sympathetic Denervation in Patients With Resistant Hypertension

842

Cardiorespiratory responses to exercise after repair of the univentricular heart

843

Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis: A Cross-Sectional Study

844

Cardiorespiratory responses to negative pressure ventilation after tetralogy of Fallot repair: hemodynamic tool for patients with low-output state

845

Cardiorespiratory Responses to Table Tennis in Low-Fit Coronary Patients and Implications for Exercise Training

846

Cardiorotective effects of a novel indole derivative with antioxidant properties against ischemic reperfusion injury

847

Cardioscopic guidance of linear lesion creation for radiofrequency ablation

848

Cardioscopic spectrum of the left ventricular endocardial surface and its relation to histologic changes in idiopathic myocarditis

849

CardioSEAL/STARflex versus Amplatzer devices for percutaneous closure of small to moderate (up to 18 mm) atrial septal defects

850

CardioSignal: A database of transcriptional regulation in cardiac development and hypertrophy

851

Cardiosource is a good source for definition of trial acronyms

852

Cardiospermum halicacabum Linn.: Food and Drug

853

Cardiothoracic Surgeons Divided By a Common Language

854

Cardiothoracic surgery in the new millennium: challenges and opportunities in a time of paradox

855

Cardiothoracic Surgery Resident Education: Update on Resident Recruitment and Job Placement

856

Cardiothoracic Surgery, 2nd Edition: by Fritz J. Baumgartner, MD, Georgetown, Texas, Landes Bioscience, 1999, 280 pages, spiral bound, $45, ISBN: 1-570-59559-3

857

Cardiothoracic surgery: a specialty in transition—good to great?

858

Cardiotin localization in mitochondria of cardiomyocytes in vivo and in vitro and its down-regulation during dedifferentiation

859

Cardiotocography and medicolegal issues

860

Cardiotocography in the Prognosis of Perinatal Outcome

861

Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial Original Research Article

862

Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial

863

Cardiotocography Waveform Analysis Using Image Extraction Technique

864

Cardiotomy Suction: A Major Source of Brain Lipid Emboli During Cardiopulmonary Bypass

865

Cardiotonic activity of methanolic extract of Saussurea lappa Linn roots

866

Cardiotonic Drugs from the Avicenna's Point of View

867

Cardiotonic Modulation in Heart Failure: Insights From Traditional Chinese Medicine

868

Cardiotoxic and Arrhythmogenic Effects of Hemiscorpius lepturus Scorpion Venom in Rats

869

Cardiotoxic Effects of Hemiscorpius Lepturus Scorpion Venom Fractions in Rats

870

Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy

871

Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique

872

Cardiotoxicité de l’association trastuzumab–radiothérapie mammaire : une étude prospective monocentrique

873

Cardiotoxicity associated with sunitinib

874

Cardiotoxicity associated with sunitinib

875

Cardiotoxicity associated with sunitinib – Authorsʹ reply

876

Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer

877

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

878

Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors

879

Cardiotoxicity of 5-flourouracil: two case reports

880

Cardiotoxicity of cytotoxic drugs

881

Cardiotoxicity of Plants in Iran: a Review

882

Cardiotoxicity of Senna occidentalis in sheep (Ovis aries)

883

Cardiotoxicity Research in Breast Cancer Patients: Past and Future

884

Cardiotoxicity With 5-Fluorouracil Based Agents: Rechallenge Cannot Currently Be Safely Advised

885

Cardiotoxicity with adjuvant trastuzumab use in breast cancer: A single institution’s experience

886

Cardiotrophin-1 in Patients with Acute Myocardial Infarction

887

Cardiotrophin-1 Induces Heat Shock Protein Accumulation in Cultured Cardiac Cells and Protects them from Stressful Stimuli

888

Cardiotrophin-1 induces proliferation and activation of primary adult rat cardiac fibroblasts

889

Cardiotrophin-1 is a prophylactic against the development of chronic hypoxic pulmonary hypertension in rats

890

Cardiotrophin-1 Phosphorylates Akt and BAD, and Prolongs Cell Survival via a PI3K-dependent Pathway in Cardiac Myocytes

891

Cardiotrophin-1 regulates osteoclast and osteoblast function in a manner distinct from other gp130 cytokines

892

Cardiovacular and cerebrovacular mortality aociated with ocular peudoexfoliation

893

Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy

894

Cardiovacular Dieae, it Rik Factor and Treatment, and Age-related Macular Degeneration: Women’ Health Initiative ight Exam Ancillary tudy Original Reearch Article

895

Cardiovacular Rik Factor and Age-related Macular Degeneration: The Lo Angele Latino Eye tudy Original Reearch Article

896

Cardiovascular Abnormalities in Cirrhosis: the Possible Mechanisms

897

Cardiovascular abnormalities in hyperthyroidism

898

Cardiovascular Abnormalities in Hyperthyroidism

899

Cardiovascular Abnormalities in Hyperthyroidism

900

Cardiovascular abnormalities in hyperthyroidism: A prospective Doppler echocardiographic study

901

Cardiovascular abnormalities in never-treated hypertensives according to nondipper status

902

Cardiovascular Abnormalities in Sickle Cell Disease

903

Cardiovascular activity and the antibody response to vaccination

904

Cardiovascular adaptations to endurance training and detraining in young and older athletes

905

Cardiovascular aging and psychometric performances: correlations in a group of ultraseptagenarian elderly

906

Cardiovascular Aging: What We Can Learn From Caloric Restriction

907

Cardiovascular and Antioxidant Effects of the Methanol Extract From the Stem Bark of Erythrina Senegalensis DC (Fabaceae)

908

Cardiovascular and autonomic nervous functions during acclimatization to hypoxia in conscious rats

909

Cardiovascular and behavioural components of conditioned fear to context after ganglionic and α-adrenergic blockade

910

Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)

911

Cardiovascular and Cancer Mortality in Very Elderly Post-Myocardial Infarction Patients Receiving Statin Treatment

912

Cardiovascular and endocrine responses to cutaneous electrical stimulation after fentanyl in the ovine fetus

913

Cardiovascular and metabolic effects of the vasopeptidase inhibitor, omapatrilat in spontaneously hypertensive rats

914

Cardiovascular and metabolic responses to two receptor-selective opioid agonists in pregnant sheep

915

Cardiovascular and Metabolic Risk Factors: How Can We Improve Outcomes in the High-Risk Patient?

916

Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68–102: The cardiovascular Health Study

917

Cardiovascular and muscle activity during chewing in whiplash-associated disorders (WAD)

918

Cardiovascular and psychosomatic symptoms among relatives of patients waiting for possible coronary revascularization

919

Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review

920

Cardiovascular and renal disease in the adolescent guinea pig after chronic placental insufficiency

921

Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats

922

Cardiovascular and Renal Effects of Hibiscus Sabdariffa Linnaeus. in Patients with Diabetic Nephropathy: A Randomized, Double-Blind, Controlled Trial

923

Cardiovascular and renal events in uncomplicated mild hypertensive patients with sustained and white coat hypertension

924

Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture

925

Cardiovascular and Respiratory Effects of Romifidine and/or Xylazine in Ketamine Anaesthesia in Dog: An Experimental Study

926

Cardiovascular and respiratory emergency dispatch due to shortterm exposure to ambient PM10 in Dezful, Iran

927

Cardiovascular and respiratory response to ascent of the Damavand summit by classic method in elite climbers

928

Cardiovascular and Systemic MicrovascularEffects of Anti-Vascular Endothelial Growth Factor Therapy for Cancer

929

Cardiovascular and ventilatory control during exercise in chronic heart failure: Role of muscle reflexes

930

Cardiovascular anomalies associated with chromosome 22q11.2 deletion

931

Cardiovascular Anomalies Associated With Chromosome 22q11.2 Deletion Syndrome

932

Cardiovascular anomalies in patients with chromosome 22q11.2 deletion: A Korean multicenter study

933

Cardiovascular applications for artifical structural proteins produced by recombinant technologies

934

Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS

935

Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease

936

Cardiovascular autonomic function in healthy adolescents

937

Cardiovascular autonomic function testing in asymptomatic T. cruzi carriers: a sensitive method to identify subclinical Chagasʹ disease

938

Cardiovascular autonomic function tests in type 2 diabetes mellitus with micro albuminuria

939

Cardiovascular autonomic modulation by nitric oxide synthases accounts for the augmented enalapril-evoked hypotension in ethanol-fed female rats

940

Cardiovascular autonomic nervous response to postural change in 610 healthy Japanese subjects in relation to age

941

Cardiovascular autonomic neuropathy in rheumatoid arthritis assessed by cardiovascular autonomic function tests: A cross-sectional survey

942

Cardiovascular autonomic regulation in Non-Obese Diabetic (NOD) mice

943

Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes

944

Cardiovascular benefits of nuts

945

Cardiovascular Care Facts: A Report From the National Cardiovascular Data Registry: 2011

946

Cardiovascular cavitation

947

Cardiovascular changes during induced emotion: An application of langʹs theory of emotional imagery

948

Cardiovascular changes in response to ovarian stimulation

949

Cardiovascular Characteristics in American Youth With Prehypertension

950

Cardiovascular characterization of Pkd2+/LacZ mice, an animal model for the autosomal dominant polycystic kidney disease type 2 (ADPKD2)

951

Cardiovascular complications and acute ischemic stroke after the treatment with epinephrine in an anaphylactic patient

952

Cardiovascular Complications in Infants of Diabetic Mothers: An Observational Study in a Pediatric Cardiology Clinic in Tehran

953

Cardiovascular Complications in Obstructive Sleep Apnea Syndrome

954

Cardiovascular complications in patients with megaesophagus due to Chagas disease undergoing the Serra-Dَria operation

955

Cardiovascular Complications of Cancer Therapy: Incidence, Pathogenesis, Diagnosis, and Management

956

Cardiovascular Complications of Chronic Opium Consumption: A Narrative Review Article

957

Cardiovascular Complications of COVID-19 in Patients With Multiple Sclerosis: A Lesson From Our Experience

958

Cardiovascular Complications of Direct Laryngoscopy vs Video Laryngoscopy in Patients over 65 Years Old

959

Cardiovascular complications of malignant carcinoid disease, ,

960

Cardiovascular Complications of Radiotherapy

961

Cardiovascular Complications of the Guillain-Barré Syndrome

962

Cardiovascular Conditions in Patients With Aluminum Phosphide Poisoning

963

Cardiovascular consequences of laparoscopic surgery

964

Cardiovascular consequences of sleep apnea: I -Epidemiology

965

Cardiovascular consequences of sleep apnea: II-Cardiovascular mechanisms

966

Cardiovascular consequences of sleep apnea: III-Impact of continuous positive airway pressure treatment

967

Cardiovascular Considerations in Antidepressant Therapy: An Evidence-Based Review

968

Cardiovascular control and plasma catecholamines during rest and mental stress: effects of posture

969

Cardiovascular control in Antarctic fish

970

Cardiovascular data on sildenafil citrate: Introduction

971

Cardiovascular Death and Cancer Death—Competing Risk?

972

Cardiovascular death from panic disorder and panic-like anxiety: A critical review of the literature

973

Cardiovascular determinants of plasma fibronectin in an elderly population: The EVA study

974

Cardiovascular disease

975

Cardiovascular Disease Among International Travellers

976

Cardiovascular disease among Mexican Americans

977

Cardiovascular disease and bone

978

Cardiovascular disease and chronic kidney disease: Insights and an update

979

Cardiovascular disease and cognitive performance in middle-aged and elderly men

980

Cardiovascular disease and mortality in statin-treated patients with familial hypercholesterolemia

981

Cardiovascular disease and neoplasms after pancreas transplantation

982

Cardiovascular disease and neoplasms after pancreas transplantation

983

Cardiovascular disease and neoplasms after pancreas transplantation

984

Cardiovascular Disease and Olympic Games in China

985

Cardiovascular disease and risk factors among 345 adults in rural India—the Andhra Pradesh Rural Health Initiative

986

Cardiovascular disease and risk factors in adults with hypopituitarism

987

Cardiovascular disease and risk factors in Montana American Indians and non-Indians Original Research Article

988

Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran

989

Cardiovascular Disease and Risk in Primary Care Settings in the United States

990

Cardiovascular disease and sexual functioning

991

Cardiovascular disease and sleep-related erections

992

Cardiovascular disease and the global tobacco epidemic: a wake-up call for cardiologists

993

Cardiovascular disease burden shifts

994

Cardiovascular disease detection using bio-sensing techniques

995

Cardiovascular disease events and its predictors in women: Isfahan Cohort Study (ICS)

996

Cardiovascular Disease in Adult and Pediatric HIV/AIDS

997

Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan

998

Cardiovascular Disease in Asian Americans: Unmasking Heterogeneity

999

Cardiovascular disease in Chinese type 2 diabetic women is associated with a prolonged QTc interval

1000

Cardiovascular Disease in Chronic Renal Failure Patients

بازگشت